These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14216140)

  • 21. The effects of acute cardiac infarction and of heparin therapy on the lipoproteins.
    BESTERMAN EM
    Br Heart J; 1958 Jan; 20(1):21-30. PubMed ID: 13499767
    [No Abstract]   [Full Text] [Related]  

  • 22. Coagulation assays.
    Bates SM; Weitz JI
    Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract]   [Full Text] [Related]  

  • 23. "THROMBOTEST" AND PROTHROMBIN TIME: A CONTROLLED CLINICAL TRIAL.
    ROZENBERG MC; KRONENBERG H; FIRKIN BG
    Australas Ann Med; 1965 Feb; 14():3-12. PubMed ID: 14271789
    [No Abstract]   [Full Text] [Related]  

  • 24. Different Heparin Contents in Prothrombin Complex Concentrates May Impair Blood Clotting in Outpatients With Ventricular Assist Devices Receiving Phenprocoumon.
    Felli A; Zeidler P; Jilma B; Opfermann P; Holaubek C; Zimpfer D; Wadowski PP; Steinlechner B
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):96-101. PubMed ID: 26613641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [EXPERIMENTAL STUDIES ON THE EFFECT OF CIGARETTE SMOKING ON THE COAGULATION TIME OF NORMAL BLOOD AND CALCIUM-TREATED BLOOD AND ON THE PROTHROMBIN AND THROMBIN TIME OF HUMAN SERUM].
    LISIEWICZ J
    Pol Tyg Lek; 1963 Sep; 18():1471-3. PubMed ID: 14082331
    [No Abstract]   [Full Text] [Related]  

  • 26. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombogenic activity of leukocytes.
    Niemetz J; Fani K
    Blood; 1973 Jul; 42(1):47-59. PubMed ID: 4717408
    [No Abstract]   [Full Text] [Related]  

  • 28. INITIAL HEPARIN THERAPY IN ACUTE MYOCARDIAL INFARCTION.
    BROWN KW; MACMILLAN RL
    Can Med Assoc J; 1964 Jun; 90(24):1345-8. PubMed ID: 14156828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of digitoxin on heparin tolerance, coagulation time, and prothrombin activity.
    LEVIN WC; RUSKIN A
    Tex State J Med; 1952 Aug; 48(8):590-3. PubMed ID: 12995310
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of aprotinin on heparinized whole blood activated clotting time and whole blood prothrombin time].
    Wen Z; Zhu F; He X; Xiong S; He S
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):304-6. PubMed ID: 9868081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. THE EFFECT OF A BOWEL STERILIZING ANTIBIOTIC ON BLOOD COAGULATION MECHANISMS. THE ANTI-CHOLESTEROL EFFECT OF PAROMOMYCIN.
    MESSINGER WJ; SAMET CM
    Angiology; 1965 Jan; 16():29-36. PubMed ID: 14258040
    [No Abstract]   [Full Text] [Related]  

  • 32. Acceleration of blood coagulation in acute myocardial infarction as demonstrated by the heparin clotting time; effect of dicumarol therapy.
    ROSENTHAL RL; WEAVER JC; BENEDEK A
    Circulation; 1952 Aug; 6(2):257-61. PubMed ID: 14936221
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacodynamic characteristics of low-molecular-weight dermatan sulphate after subcutaneous administration in acute myocardial infarction.
    Traini AM; Cervi V; Melandri G; Palazzini E; Zamboni V; Semprini F; Candiotti N; Branzi A
    J Int Med Res; 1994; 22(6):323-31. PubMed ID: 7895895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction.
    Wang XK; Zhang Y; Yang CM; Wang Y; Liu GY
    Clin Drug Investig; 2006; 26(6):341-9. PubMed ID: 17163268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heparin tolerance test and prothrombin time in the control of anticoagulant therapy of coronary infarction].
    HOLLER G; WEINMANN O; HAMMERL H; ZEMANN J
    Wien Klin Wochenschr; 1953 May; 65(20):402-4. PubMed ID: 13078388
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of the xanthine derivatives on the prothrombin and plasma clotting times in dogs and in human subjects.
    HOLLAND H; GROSS EG
    J Iowa State Med Soc; 1948 May; 38(5):183-7. PubMed ID: 18862357
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes in the coagulation activity of the blood during reversible myocardial infarct].
    Orlova NP; El'gort PE
    Kardiologiia; 1967 Oct; 7(10):26-8. PubMed ID: 5607195
    [No Abstract]   [Full Text] [Related]  

  • 38. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring heparin therapy with the activated partial thromboplastin time.
    Stuart RK; Michel A
    Can Med Assoc J; 1971 Mar; 104(5):385-8. PubMed ID: 5557913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of the heparin clotting time (heparin prothrombin time).
    LOSNER S; VOLK BW
    Tech Bull Regist Med Technol; 1957 Feb; 27(2):35-41. PubMed ID: 13422312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.